DOMICAPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DOMICAPHARMA
Largest movements
- Cash +€160,688
up €160,688 (+104%), from €154,156 to €314,844
mainly Receivables within one year (+€68,346) and Net result for the year (+€46,457)
- Receivables within one year -€68,346
down €68,346 (-28.6%), from €238,652 to €170,306
of which Other amounts receivable: -€55,362
- Tangible fixed assets -€22,921
down €22,921 (-43.0%), from €53,266 to €30,345
of which Other tangible fixed assets: -€21,414
- Stocks and contracts -€11,146
down €11,146 (-6.4%), from €173,831 to €162,685
- Other debts +€44,701
up €44,701 (+56.5%), from €79,098 to €123,799
- Tax, wage and social debts +€7,431
up €7,431 (+113%), from €6,566 to €13,997
of which Remuneration and social security: +€7,438
- Staff costs +€30,401
up €30,401 (+28.7%), from €106,000 to €136,402
- Gross operating margin +€11,604
up €11,604 (+6.0%), from €193,590 to €205,194
- Depreciation -€2,665
down €2,665 (-10.4%), from €25,586 to €22,921
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €631,480 | €690,248 | +€58,767 | +9.3% |
| Fixed assets | 21/28 | €62,067 | €39,146 | -€22,921 | -36.9% |
| Tangible fixed assets | 22/27 | €53,266 | €30,345 | -€22,921 | -43.0% |
| Plant, machinery and equipment | 23 | €901 | €450 | -€451 | -50.0% |
| Furniture and vehicles | 24 | €2,725 | €1,668 | -€1,056 | -38.8% |
| Other tangible fixed assets | 26 | €49,641 | €28,227 | -€21,414 | -43.1% |
| Financial fixed assets | 28 | €8,801 | €8,801 | = | 0.0% |
| Current assets | 29/58 | €569,413 | €651,102 | +€81,689 | +14.3% |
| Stocks and contracts in progress | 3 | €173,831 | €162,685 | -€11,146 | -6.4% |
| Stocks | 30/36 | €173,831 | €162,685 | -€11,146 | -6.4% |
| Amounts receivable within one year | 40/41 | €238,652 | €170,306 | -€68,346 | -28.6% |
| Trade receivables | 40 | €74,771 | €61,788 | -€12,984 | -17.4% |
| Other amounts receivable | 41 | €163,881 | €108,518 | -€55,362 | -33.8% |
| Cash at bank and in hand | 54/58 | €154,156 | €314,844 | +€160,688 | +104% |
| Deferred charges and accrued income | 490/1 | €2,774 | €3,267 | +€493 | +17.8% |
| Total equity and liabilities | 10/49 | €631,480 | €690,248 | +€58,767 | +9.3% |
| Equity | 10/15 | €425,034 | €426,491 | +€1,457 | +0.3% |
| Contributions | 10/11 | €10,755 | €10,755 | = | 0.0% |
| Reserves | 13 | €414,279 | €415,736 | +€1,457 | +0.4% |
| Tax-exempt reserves | 132 | €30,523 | €30,523 | = | 0.0% |
| Distributable reserves | 133 | €383,756 | €385,213 | +€1,457 | +0.4% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €206,446 | €263,756 | +€57,310 | +27.8% |
| Amounts payable within one year | 42/48 | €206,446 | €263,643 | +€57,197 | +27.7% |
| Trade debts | 44 | €119,080 | €125,847 | +€6,767 | +5.7% |
| Suppliers | 440/4 | €119,080 | €125,847 | +€6,767 | +5.7% |
| Advances received on contracts in progress | 46 | €1,702 | €0 | -€1,702 | -100% |
| Taxes, remuneration and social security | 45 | €6,566 | €13,997 | +€7,431 | +113% |
| Taxes | 450/3 | €7 | €0 | -€7 | -100% |
| Remuneration and social security | 454/9 | €6,558 | €13,997 | +€7,438 | +113% |
| Other amounts payable | 47/48 | €79,098 | €123,799 | +€44,701 | +56.5% |
| Accrued charges and deferred income | 492/3 | - | €113 | +€113 | |
| Remuneration, social security and pensions | 62 | €106,000 | €136,402 | +€30,401 | +28.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €25,586 | €22,921 | -€2,665 | -10.4% |
| Other operating charges | 640/8 | €406 | €274 | -€132 | -32.4% |
| Gross operating margin | 9900 | €193,590 | €205,194 | +€11,604 | +6.0% |
| Operating profit (loss) | 9901 | €61,598 | €45,597 | -€16,001 | -26.0% |
| Financial income | 75/76B | €1,054 | €2,301 | +€1,247 | +118% |
| Recurring financial income | 75 | €1,054 | €2,301 | +€1,247 | +118% |
| Financial charges | 65/66B | €99 | €51 | -€48 | -48.7% |
| Recurring financial charges | 65 | €99 | €51 | -€48 | -48.7% |
| Profit (loss) for the period before taxes | 9903 | €62,553 | €47,847 | -€14,706 | -23.5% |
| Income taxes | 67/77 | €2,625 | €1,390 | -€1,235 | -47.0% |
| Profit (loss) for the period | 9904 | €59,928 | €46,457 | -€13,471 | -22.5% |
| Profit (loss) for the period to be appropriated | 9905 | €59,928 | €46,457 | -€13,471 | -22.5% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.